Attomarker wins the ‘One to Watch’ award at the UK’s prestigious OBN Life Sciences event in Oxford

Nov 8, 2019

The annual OBN Life Sciences Awards, now in their 11th year, attracts the great, the good, and the up and coming of the UK life sciences industry, 300 of whom attended last night’s ceremony in Oxford.

Celebrating innovation and achievement in the life sciences sector, one of the key awards is Bioseed’s ‘One to Watch’, which this year was won by Attomarker.

The citation declared that “The judges felt that the winner of this category has achieved more than others, that they have an on-trend technology and are moving forward commercially. The judges commended their patient-centric approach and felt they were achieving good progress in a tricky market.”

Professor Andrew Shaw, University of Exeter & Founder/CEO of Attomarker Ltd, with Matthew Clarke of Merlin Partners LLP